Filing Details

Accession Number:
0001209191-23-018065
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-10 21:58:15
Reporting Period:
2023-03-08
Accepted Time:
2023-03-10 21:58:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1775295 Christine Chung C/O Fibrogen, Inc.
409 Illinois St.
San Francisco CA 94158
Svp, China Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-08 8,354 $21.16 251,519 No 4 S Direct
Common Stock Acquisiton 2023-03-08 5,799 $0.00 257,318 No 4 A Direct
Common Stock Acquisiton 2023-03-08 9,338 $0.00 266,656 No 4 A Direct
Common Stock Disposition 2023-03-10 4,692 $20.20 261,964 No 4 S Direct
Common Stock Disposition 2023-03-10 2,914 $20.20 259,050 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
No 4 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
  2. Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
  3. Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
  4. Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.
  5. Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.